March 27, 2020
The COVID-19 outbreak has triggered new rounds of clinical trials to identify treatments for the coronavirus.
January 7, 2020
Reps. Diana DeGette and Fred Upton, who authored the 21st Century Cures Act in 2016, announced last year their intention to update the bill in 2020.
June 7, 2019
Elated. Nervous. Hopeful. That’s how thousands of cystic fibrosis patients felt upon hearing last week’s news: the Food and Drug Administration will soon review a new triple combination therapy that could drastically improve their quality of life.
June 5, 2019
The Institute for Clinical and Economic Review is dashing patients’ hopes yet again.
April 9, 2019
Patients, in consultation with their doctors, should make their own medical decisions. But with increasing frequency, an outside organization known…
April 9, 2019
Policymakers, providers and patients all feel the impact of The Institute for Clinical and Economic Review, whose ubiquitous cost-effectiveness reports can determine patients’ access to medicine.
October 4, 2018
Let me share the story of one of my patients who suffers from severe eczema.
October 2, 2018
Oklahoma is leading the nation when it comes to innovative drug pricing approaches.
September 7, 2018
When it comes to how to increase the development and utilization of biosimilars, the Food and Drug Administration is all ears. On Tuesday, the agency welcomed numerous physicians and experts to testify on competition and innovation in the biosimilars marketplace. And at least one physician identified a critical component in uptake: physician confidence.
July 3, 2018
What can America learn at the crossroads of social media and clinical trials? At a recent National Institutes of Health workshop, one organization had a clear answer: powerful methods for heightening clinical trials awareness.